膀胱癌

pánɡ ɡuānɡ ái
  • bladder cancer
膀胱癌膀胱癌
  1. 卡介苗和猪苓多糖对膀胱癌细胞TLR2/4-NF-κB信号通路的影响

    Effect of BCG and Polyporus Polysaccharide on TLR2 / 4-NF - κ B Signal Pathway in Bladder Cancer Cell

  2. 丝裂霉素C联合C2-神经酰胺对人膀胱癌T(24)细胞生长的抑制作用

    Inhibition effect of combining mitomycin C with C_2-ceramide on human bladder cancer T_24 cells

  3. Western印迹法检测处理后膀胱癌细胞组蛋白乙酰化水平的变化;

    The acetyl level of histone after TSA treatment was detected by Western blot ;

  4. 高分级膀胱癌多药耐受相关蛋白和P糖蛋白表达模式的意义

    Patterns of Expression in the Multidrug Resistance associated Protein Versus P glycoprotein in High grade Bladder Cancer

  5. 应用DNA图像定量分析技术进行膀胱癌中DNA定量检测。

    DNA parameters in patients with bladder cancer were determined by DNA image cytometry .

  6. CT薄层增强扫描对膀胱癌术前分期的价值

    Evaluation of Enhanced Scans by Thin Slice CT in Clinical Staging of Pre-operation Bladder Carcinoma

  7. 胸甘酸合酶mRNA在膀胱癌中的表达及其临床意义

    Expression and clinical significance of thymidylate synthase mRNA in bladder cancer

  8. 高危性人乳头瘤病毒与抑癌基因P53在膀胱癌中的表达

    High risk human papillomavirus and P53 protein expression in bladder cancer

  9. 膀胱癌转化生长因子α和P53基因表达及生物学意义

    Transforming growth factor α and P53 gene expression in bladder cancer

  10. 免疫细胞化学技术检测P-糖蛋白在人膀胱癌MDR细胞亚株中的表达

    Detection of P-glycoprotein expression with immunocytochemistry in adriamycin-resistant human bladder cancer cell line

  11. 从膀胱癌尿脱落细胞中提取RNA进行RT-PCR的研究

    RT-PCR study on RNA extracted from urine exfoliated cells of bladder cancer

  12. 方法分析13例膀胱癌的CT表现及术前分期,并与手术病理结果对照。

    Methods CT findings and preoperative staging of 13 patients with bladder cancer were analyzed and correlated with postoperative pathologic findings .

  13. 人膀胱癌耐药细胞株p53基因突变与染色体畸变的关系

    The relationship between p53 mutation in drug-resistance lines of bladder cancer and chromosome aberration

  14. 尿脱落细胞CD(44)基因变异表达产物对膀胱癌诊断价值的研究

    Significance of urine exfoliated cells abnormal CD_ ( 44 ) gene expression products for bladder cancer diagnosis

  15. 目的研究乳腺癌、膀胱癌和肾癌组织中cMyc基因扩增情况。

    Objective To study the amplification of c - myc gene in different tumors .

  16. 术前动脉化疗对膀胱癌p53和PCNA表达的影响

    Influence of Preoperative Arterial Chemotherapy on Expression of p53 and PCNA in Bladder Cancer

  17. 膀胱癌IL-2基因瘤苗诱导的抗肿瘤免疫反应

    Induction of anti tumor immunity by IL 2 gene transferred bladder cancer vaccine

  18. FISH技术对提高人群膀胱癌早期诊断及评估膀胱癌预后具有重要的临床应用价值。

    FISH has important clinical value in the promotion of diagnosis of the early bladder cancer and estimating prognosis of bladder cancer .

  19. rasp21和P53在膀胱癌表达的临床意义

    Expression of ras P21 and P53 in bladder cancer

  20. 方法:应用PCRSSCP银染和DNA测序技术对31例膀胱癌组织进行检测。

    Methods 31 cases of bladder carcinoma were detected by PCR SSCP silver staining and DNA sequencing .

  21. 新辅助化疗对浸润性膀胱癌预后影响的Meta分析

    Meta-Analysis of effect of adjuvant chemotherapy on prognosis of muscular-invasive bladder cancer

  22. AS2O3抑制人膀胱癌细胞体外生长及机制

    Study of the growth inhibition and mechanism of human bladder cancer cells by arsenic trioxide in vitro

  23. Fas配体在膀胱癌中的表达及意义

    Expression of Fas ligand in bladder neoplasms

  24. 粘膜下注射5-Fu预防膀胱癌复发

    Preventing the recurrence of bladder carcinoma by submucous injecting 5-Fu

  25. MDM2和p53蛋白在膀胱癌中过度表达的意义

    Clinical significance of over expression of MDM2 and p53 protein in bladder cancer

  26. 浅表性膀胱癌组织学形态及Ki-67、p53表达与肿瘤复发的关系

    The correlation between recurrence of superficial bladder cancer and histology manifestation or Ki-67 , p53 expression

  27. T2和T3期膀胱癌术后放射治疗及膀胱内灌注化疗疗效分析

    Postoperative radiotherapy combined with intravesical chemotherapy for T2 / T3 bladder cancer

  28. 热休克蛋白70反义寡核苷酸对膀胱癌细胞系EJ细胞对丝裂霉素C敏感性的影响

    The heat shock protein 70 antisense oligomers enhance the sensitivity of bladder cancer cell EJ to mitomycin C

  29. 目的探讨细胞角蛋白19(cytokeratin19,CK19)mRNA在膀胱癌组织中的表达及临床意义。

    Objective To investigate the expression and clinical significance of cytokeratin 19 mRNA in bladder carcinomas .

  30. RT-PCR方法检测外周血CK-20在膀胱癌微转移灶的临床意义

    Clinical significance of micrometastasis of bladder carcinoma detected by CK-20 RT-PCR